| Financier | Commitments |
|---|---|
| IDA Credit | 125.00 |
Additional Financing NG-Polio Eradication Support Project
Development Objective
To assist the Recipient, as part of a global polio eradication effort, to achieve and sustain at least 80 percent coverage with oral polio vaccine immunization in every state in the Recipient’s territory, and improve national routine immunization coverage.
Key Details
Project Details
P158557
Closed
Ayodeji Odutolu , Ana Besarabic, Shunsuke Mabuchi
N/A
June 7, 2016
(as of board presentation)
June 7, 2016
N/A
US$ 125.00 million
N/A
2016
US$ 125.00 million
C
March 27, 2024
April 30, 2021
Yes
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 125.00 |
| IBRD + IDA Commitment | 125.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 125.00 |
Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025
No data available.
Detailed Financial Activity as of February 28, 2025
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Immunization coverage of OPV in the country Value 91.80 95.60 80.00 Date December 31, 2012 January 31, 2016 December 31, 2018 Comment Data source: LQAS 2012 Data source: 2015 Performance Audit Data source: 2018 Performance Audit Immunization coverage of OPV in each high risk state Value 89.00 95.60 80.00 Date December 31, 2012 January 31, 2016 December 31, 2018 Comment Data source: LQAS 2012 Data source: 2015 Performance Audit Data source: 2018 Performance Audit Children immunized (number) Value 0.00 5479402.00 6561446.00 Date July 9, 2012 October 30, 2015 December 31, 2018 Comment Direct project beneficiaries Value 0.00 5479402.00 6561446.00 Date July 9, 2012 October 30, 2015 December 31, 2018 Comment Data source: DHIS2 Data source: DHIS2 Children immunized - under 12 months against DTP3 (number) Value 0.00 3304952.00 3465493.00 Date July 9, 2012 December 31, 2015 December 31, 2018 Comment Data source: DHIS2 Data source: DHIS2 Female beneficiaries Value 0.00 50.00 50.00 Date July 9, 2012 October 30, 2015 December 31, 2018 Comment Pentavalent 3 coverage rate Value 52.00 48.80 52.00 Date May 5, 2014 September 15, 2015 December 31, 2018 Comment Data Source: SMART Survey Data Source: SMART Survey Data Source: SMART Survey
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of teams with viable vaccine according to the Vaccine Vial Monitor Value 97.00 98.00 98.00 Date April 15, 2012 October 30, 2015 December 31, 2018 Comment Data Source: WHO Campaign Reports (frequency: every round) Data Source: WHO Campaign Reports (frequency: every round) Data Source: WHO Campaign Reports (frequency: every round) Percentage of campaigns where vaccines are available on time Value 100.00 100.00 100.00 Date July 9, 2012 October 30, 2015 December 31, 2018 Comment Data Source: WHO and UNICEF Campaign Reports (frequency: every round) Data Source: WHO and UNICEF Campaign Reports (frequency: every round) Data Source: WHO and UNICEF Campaign Reports (frequency: every round) Pentavalent 3 coverage rate Value 52.00 52.00 52.00 Date May 5, 2014 September 25, 2015 May 31, 2017 Comment Data source: SMART Survey Percentage of health facilities in the project area with functioning management committees having community representation Value 0.00 0.00 30.00 Date May 23, 2016 May 23, 2016 December 31, 2018 Comment Data source: SMART Survey Data source: SMART Survey